We are live on ! Find out more
AL

Aspiriant LLC Portfolio holdings

AUM $3.51B
1-Year Est. Return 13.98%
This Fund
S&P 500
This Quarter Est. Return
+2.8%
1 Year Est. Return
+13.98%
3 Year Est. Return
+39.43%
5 Year Est. Return
+43.32%
10 Year Est. Return
+133.07%
AUM
$1.19B
AUM Growth
+$43.3M
Cap. Flow
+$12.3M
Cap. Flow %
1.03%
Top 10 Hldgs %
46.73%
Holding
223
New
13
Increased
40
Reduced
126
Closed
20

Sector Composition

1 Financials 4.79%
2 Technology 2.81%
3 Communication Services 2.42%
4 Healthcare 1.93%
5 Consumer Staples 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
META icon
26
Meta Platforms (Facebook)
META
$1.64T
$11.4M 0.96%
66,742
-206
-0.3% -$34.4K
IWD icon
27
iShares Russell 1000 Value ETF
IWD
$81.9B
$10.2M 0.86%
86,361
+9,915
+13% +$1.16M
IEFA icon
28
iShares Core MSCI EAFE ETF
IEFA
$186B
$9.38M 0.79%
146,225
+356
+0.2% +$22.3K
SCHX icon
29
Schwab US Large- Cap ETF
SCHX
$71.7B
$9.28M 0.78%
927,558
-255,606
-22% -$2.51M
EEM icon
30
iShares MSCI Emerging Markets ETF
EEM
$28B
$9.26M 0.78%
206,688
-2,983
-1% -$131K
CINF icon
31
Cincinnati Financial
CINF
$28B
$9.08M 0.76%
118,602
-4,615
-4% -$351K
SCHM icon
32
Schwab US Mid-Cap ETF
SCHM
$14.6B
$8.53M 0.72%
510,930
-103,677
-17% -$1.69M
VWO icon
33
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$8.5M 0.71%
195,126
-12,835
-6% -$555K
VTIP icon
34
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$8.48M 0.71%
171,440
+103,000
+150% +$5.09M
VV icon
35
Vanguard Large-Cap ETF
VV
$52.2B
$8.26M 0.69%
71,533
+59,218
+481% +$6.71M
IGSB icon
36
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
$6.66M 0.56%
+126,376
New +$6.66M
PG icon
37
Procter & Gamble
PG
$349B
$6.63M 0.56%
72,816
-5,891
-7% -$536K
SCHZ icon
38
Schwab US Aggregate Bond ETF
SCHZ
$10.6B
$6.14M 0.51%
234,628
+42,932
+22% +$1.13M
JNJ icon
39
Johnson & Johnson
JNJ
$609B
$6.12M 0.51%
47,082
-3,953
-8% -$524K
RY icon
40
Royal Bank of Canada
RY
$299B
$5.96M 0.5%
77,000
-3,500
-4% -$261K
BNDX icon
41
Vanguard Total International Bond ETF
BNDX
$82.2B
$5.83M 0.49%
+106,832
New +$5.83M
ACWX icon
42
iShares MSCI ACWI ex US ETF
ACWX
$11.3B
$5.69M 0.48%
+117,717
New +$5.56M
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.23T
$5.59M 0.47%
114,920
-3,360
-3% -$159K
USB icon
44
US Bancorp
USB
$98.4B
$5.11M 0.43%
95,276
-10,352
-10% -$542K
CVX icon
45
Chevron
CVX
$373B
$4.16M 0.35%
35,389
-5,821
-14% -$635K
JPM icon
46
JPMorgan Chase
JPM
$907B
$4.14M 0.35%
43,330
-13,093
-23% -$1.21M
IWR icon
47
iShares Russell Mid-Cap ETF
IWR
$56.6B
$3.88M 0.33%
78,832
-11,180
-12% -$540K
PEP icon
48
PepsiCo
PEP
$187B
$3.88M 0.33%
34,806
-5,136
-13% -$593K
VCIT icon
49
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.7B
$3.61M 0.3%
41,016
-23,917
-37% -$2.1M
MSFT icon
50
Microsoft
MSFT
$2.93T
$3.55M 0.3%
47,696
+1,341
+3% +$98K

Similar funds

Aspiriant LLC's Q3 2017 Portfolio in Review

As of Q3 2017, Aspiriant LLC held 223 positions worth $1.19B, up 3.8% from $1.15B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Aspiriant LLC's Q3 2017 filing shows 13 new, 40 increased, 126 reduced and 20 closed positions. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 126,376 shares worth $6.66M. The largest sale was Schwab US TIPS ETF, an estimated $8.11M.

By sector, the portfolio is most concentrated in Financials at 4.8% of assets, down from 5.3% a quarter earlier, followed by Technology and Communication Services.

  • Aspiriant LLC's largest Q3 2017 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 126,376 shares worth $6.66M.
  • Aspiriant LLC added most to iShares MSCI EAFE ETF in Q3 2017, an estimated $15.5M increase.
  • Aspiriant LLC's biggest Q3 2017 reduction was Schwab US TIPS ETF, cutting an estimated $8.11M.
  • Aspiriant LLC fully exited Twilio in Q3 2017, selling an estimated $2.15M.
  • Aspiriant LLC's ten largest holdings make up 47% of its $1.19B portfolio in Q3 2017.
  • Aspiriant LLC opened 13 new positions and closed 20 in Q3 2017.
  • Aspiriant LLC's portfolio value rose 3.8% quarter-over-quarter to $1.19B.

Based on Aspiriant LLC's 13F filing for Q3 2017, filed 13 Nov 2017.